Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-12

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals Limited's original application for a generic irbesartan/hydrochlorothiazide combination tablet for the treatment of hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)